Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
23 hedge funds and large institutions have $2.24M invested in Bio-Path Holdings Inc in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 9 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
18% less capital invested
Capital invested by funds: $2.73M → $2.24M (-$492K)
21% less funds holding
Funds holding: 29 → 23 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$133K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$84.2K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$32K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$21.8K |
| 5 |
Goldman Sachs
New York
|
+$19.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$272K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$191K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$157K |
| 4 |
Millennium Management
New York
|
-$113K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$10K |
BPTH Hedge Fund Activity: Q1 2018 in Review
23 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2018, worth a combined $2.24M — down 18% from $2.73M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BPTH and 3 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was Renaissance Technologies, adding an estimated $133K. The largest seller was Anson Funds Management, exiting entirely with an estimated $272K sold.
- 23 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2018, down from 29 in Q4 2017.
- Funds reported $2.24M of Bio-Path Holdings Inc stock for Q1 2018, down 18% quarter-over-quarter.
- 3 funds opened new Bio-Path Holdings Inc positions in Q1 2018 and 9 closed out, a net change of -6 holders.
- The largest Bio-Path Holdings Inc buyer in Q1 2018 was Renaissance Technologies, an estimated $133K added.
- The largest Bio-Path Holdings Inc seller in Q1 2018 was Anson Funds Management, an estimated $272K sold.
Based on aggregated 13F filings for Q1 2018.